drugset / Trial / NCT01217905

Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687

NCT01217905 ↗

Phase 1 Completed 36 enrolled AstraZeneca
RandomizedSingle-groupDouble-blindBasic science

Summary

This is a study in Japanese healthy volunteers to determine the safety and tolerability of the compound AZD7687. It will also assess how the body handles the drug and how it responds to the drug following single dose followed by multiple dosing over 7 days.

Timeline

Start
2010-11
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7687 Small molecule — Oral